<?xml version="1.0" encoding='utf-8'?>
<!DOCTYPE wml PUBLIC "-//WAPFORUM//DTD WML 1.1//EN" "http://www.wapforum.org/DTD/wml_1.1.xml">
<wml>
<card id="card1" title="Dihydrotestosterone - Page 10 - Wikipedia">
<p>
<a accesskey="1" href="page.php?w=dihydrotestosterone&amp;p=9">1.Previous</a><br />
<a accesskey="3" href="page.php?w=dihydrotestosterone&amp;p=11">3.Next</a>
</p>
<p><a href="page.php?w=5%3F-Reductase_inhibitor">5?-Reductase inhibitor</a>s, which prevent DHT synthesis, are effective in the prevention and treatment of these conditions. Androgen deprivation is a therapeutic approach to prostate cancer that can be implemented by castration to eliminate gonadal testosterone as a precursor to DHT, but metastatic tumors may then develop into castration-resistant prostate cancer (CRPC). Although castration results in 90-95% decrease of serum testosterone, DHT in the prostate is only decreased by 50%, supporting</p><p>
<a accesskey="1" href="page.php?w=dihydrotestosterone&amp;p=9">1.Previous</a><br />
<a accesskey="3" href="page.php?w=dihydrotestosterone&amp;p=11">3.Next</a>
</p>

<do type="prev" label="Search">
        <go href="search.wml"/>
</do>

</card>
</wml>
